Member Company is a pioneering healthcare company focused on transforming cardiovascular care through innovative digital solutions. Our flagship product, OptiCor, is the only Clinical Decision Support Tool that integrates the precision medicine approach of the 2023 ACC/AHA/HRS Guideline for Atrial Fibrillation. Developed by physicians for physicians, OptiCor provides precise risk predictions and treatment recommendations, improving patient outcomes and reducing healthcare costs. Backed by robust clinical evidence and seamless EHR integration, tenacio is at the forefront of enhancing cardiovascular health.

Publication of our study in the European Heart Journal Digital Health:

Copyright © 2024 Digital Therapeutics Alliance™